GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PT Merck Tbk (GREY:PMKIF) » Definitions » ROE % Adjusted to Book Value

PT Merck Tbk (PT Merck Tbk) ROE % Adjusted to Book Value : 0.00% (As of Mar. 2024)


View and export this data going back to 2012. Start your Free Trial

What is PT Merck Tbk ROE % Adjusted to Book Value?

PT Merck Tbk's ROE % for the quarter that ended in Mar. 2024 was 11.71%. PT Merck Tbk's PB Ratio for the quarter that ended in Mar. 2024 was N/A. PT Merck Tbk's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was N/A.


PT Merck Tbk ROE % Adjusted to Book Value Historical Data

The historical data trend for PT Merck Tbk's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Merck Tbk ROE % Adjusted to Book Value Chart

PT Merck Tbk Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

PT Merck Tbk Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of PT Merck Tbk's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, PT Merck Tbk's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Merck Tbk's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PT Merck Tbk's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where PT Merck Tbk's ROE % Adjusted to Book Value falls into.



PT Merck Tbk ROE % Adjusted to Book Value Calculation

PT Merck Tbk's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=23.18% / N/A
=N/A

PT Merck Tbk's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=11.71% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PT Merck Tbk ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of PT Merck Tbk's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Merck Tbk (PT Merck Tbk) Business Description

Traded in Other Exchanges
Address
Jalan T.B. Simatupang No. 8, Pasar Rebo, Jakarta Timur, IDN, 13760
PT Merck Tbk engages in the manufacture and sale of pharmaceutical products in Indonesia. The company operates in three segments: Biopharma, Consumer Health, and Others. The company offers pharmaceutical and biological prescription medicines to treat cancer, multiple sclerosis, infertility, growth disorders, and cardiovascular and metabolic diseases, as well as chronic diseases.

PT Merck Tbk (PT Merck Tbk) Headlines

No Headlines